dapagliflosin/saxagliptin

dapagliflosin/saxagliptin, jise brand naam cturn key tahat becha jaataa haye, ack nishchit khuraak sanyojan anty-diabetic dawa haye jiska upayog aahar aur vyayam key sahayak key roop mein kiya jaataa haye taaki type 2 madhumeh vaale vayaskon mein glycemic niyantran mein sudhaar kiya jaa sakey. yeh dapagliflosin aur saxagliptin kaa ack sanyojan haye. ise munh seey liya jaataa haye.
sabse aam dushprabhavon mein oopari shwasan path kaa sankraman (jaise naak aur galey kaa sankraman) aur, jaba sulphonyluria, hypoglycemia (rakt sharkara kaa nimn star) key saath upayog kiya jaataa haye.
europeeya sangh mein julaai 2016 mein aur sanyukt raajya america mein farwari 2017 mein chikitsa upayog key liye dapagliflosin/saxagliptin koo manjuri dee gaee thee.
chikitsa upayog.
sanyukt raajya america mein type 2 madhumeh vaale vayaskon mein glycemic niyantran mein sudhaar key liye aahar aur vyayam key liye ack sahayak key roop mein dapagliflosin/saxagliptin kaa sanket diyaa jaataa haye.
europeeya sangh mein yeh 18 varsh aur usase adhik ayu key vayaskon mein type 2 madhumeh key saath sanket diyaa gayaa haih

